GoldenGolden
Advanced Search
BroadOak Capital Partners

BroadOak Capital Partners

BroadOak, and its principals, are active investors in life sciences companies having participated in over 25 investments in the public and private markets.

BroadOak Capital Partners is a privately-held investment bank with a comprehensive focus on the life sciences industry. The firm offers advisory services including mergers and acquisitions, divestitures, capital formation, valuations and fairness opinions. Their sector focus includes research tools and consumables, diagnostics, therapeutics, healthcare IT, pharmaceutical services and medical devices. BroadOak was established in 2006 and is headquartered in Bethesda, Maryland

Investment

BroadOak Capital Partners' investments include Horizon Infusions, Particle Dynamics, Argonaut Manufacturing Services, Honeycomb Biotechnologies, rareLife Solutions, Azure Biosystems, SGI-DNA, seqWell and Reaction Biology Corporation.

Timeline

People

Name
Role
LinkedIn

Aaron Fisher

Vice President

Matt McFarland

Managing Director

Further reading

Title
Author
Link
Type
Date

Documentaries, videos and podcasts

Title
Date
Link

Companies

Company
CEO
Location
Products/Services

References

Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.